| # | Title | Journal | Year | Citations |
|---|
| 1 | Discovery of Potential Inhibitors of SARS-CoV-2 (COVID-19) Main Protease (Mpro) from Nigella Sativa (Black Seed) by Molecular Docking Study | Coronaviruses | 2021 | 23 |
| 2 | COVID-19: Could Irisin Become the Handyman Myokine of the 21st Century? | Coronaviruses | 2020 | 18 |
| 3 | Coronavirus Disease 2019 (COVID-19): Current Situation and Therapeutic Options | Coronaviruses | 2021 | 17 |
| 4 | The Effects of Coronavirus (COVID-19) on the Psychological Health of Indian Poultry Farmers | Coronaviruses | 2021 | 10 |
| 5 | Molecular Insights into Resveratrol and Its Analogs as SARS-CoV-2 (COVID-19) Protease Inhibitors | Coronaviruses | 2021 | 10 |
| 6 | COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario | Coronaviruses | 2020 | 10 |
| 7 | Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools | Coronaviruses | 2020 | 8 |
| 8 | nCovid-19 in 2020: From Despair to Hope | Coronaviruses | 2020 | 7 |
| 9 | Is COVID-19 a Systemic Disease? | Coronaviruses | 2021 | 7 |
| 10 | Safe Use of Sodium Dodecyl Sulfate (SDS) to Deactivate SARS-CoV-2: An Evidence-Based Systematic Review | Coronaviruses | 2021 | 7 |
| 11 | Potential Drug Options for Treatment of COVID-19: A Review | Coronaviruses | 2020 | 7 |
| 12 | Administration of Exogenous Surfactant and Cytosolic Phospholipase A2α Inhibitors may Help COVID-19 Infected Patients with Chronic Diseases | Coronaviruses | 2021 | 6 |
| 13 | Prediction of Infection and Death Ratio of COVID-19 Virus in Turkey by Using Artificial Neural Network (ANN) | Coronaviruses | 2021 | 6 |
| 14 | Impact of Online Teaching on Students’ Education and Health in India during the Pandemic of COVID-19 | Coronaviruses | 2021 | 6 |
| 15 | Antiviral Potential of Coconut (Cocos nucifera L.) Oil and COVID-19 | Coronaviruses | 2021 | 6 |
| 16 | Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach | Coronaviruses | 2020 | 6 |
| 17 | Activity of Some Novel Chalcone Substituted 9-anilinoacridines against Coronavirus (COVID-19): A Computational Approach | Coronaviruses | 2020 | 6 |
| 18 | A coadunation of biological and mathematical perspectives on the pandemic COVID-19: A Review | Coronaviruses | 2021 | 5 |
| 19 | Virtual Screening of Potential Therapeutic Inhibitors Against Spike, Helicase, and Polymerase of SARS-CoV-2 (COVID-19) | Coronaviruses | 2021 | 5 |
| 20 | Impacts and Consequences of COVID-19 Epidemic on Global Economy | Coronaviruses | 2021 | 5 |
| 21 | Green Tea Catechins Against COVID-19: Lower COVID-19 Morbidity and Mortality in Countries with Higher per capita Green Tea Consumption | Coronaviruses | 2022 | 5 |
| 22 | Clinical evidence and therapeutic treatments at the time of the coronaviruses responsible for SARS: a perspective and points of view with a focus on vascular endothelium. | Coronaviruses | 2021 | 4 |
| 23 | Insights into the Positive Role of a Higher Education Institution in the Prevention of Misinformation During Pandemics: The Health Committee Model During COVID-19 | Coronaviruses | 2021 | 4 |
| 24 | Dealing with COVID-19: Lessons Learned from the Italian Experience | Coronaviruses | 2021 | 4 |
| 25 | Vaccine Development Against SARS-CoV-2: From Virology to Vaccine Clinical Trials | Coronaviruses | 2021 | 4 |
| 26 | Non-Pharmaceutical Interventions are Measures to Control Coronavirus Disease-2019 (COVID-19) Transmission in India | Coronaviruses | 2021 | 4 |
| 27 | Adjuvant Therapies of COVID-19 - A Literature Review | Coronaviruses | 2021 | 4 |
| 28 | Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update | Coronaviruses | 2021 | 4 |
| 29 | Revealing Potential Binding Affinity of FDA Approved Therapeutics Targeting Main Protease (3CLpro) in Impairing Novel Coronavirus (SARSCoV- 2) Replication that Causes COVID-19 | Coronaviruses | 2020 | 4 |
| 30 | COVID-19: A Review on Epidemiology, Clinical Features and Possible Potential Drugs Based on Available Case Studies | Coronaviruses | 2021 | 3 |
| 31 | Natural Products as Anti-COVID-19 Agents: An In Silico Study | Coronaviruses | 2021 | 3 |
| 32 | Mechanism of Action of Chloroquine/Hydroxychloroquine for Covid-19 Infection | Coronaviruses | 2021 | 3 |
| 33 | Structure Based Drug Design Approach to Identify Potential SARS-CoV-2 Polymerase Inhibitors | Coronaviruses | 2021 | 3 |
| 34 | In Silico Identification of Potential Inhibitors of SARS-CoV-2 Papain-like Protease From Natural Sources: A Natural Weapon to Fight COVID-19 | Coronaviruses | 2021 | 3 |
| 35 | Study of SARS-nCoV2 Indian Isolates Gaining Insights into Mutation Frequencies, Protein Stability and Prospective Effect on Pathogenicity | Coronaviruses | 2021 | 3 |
| 36 | A Note on the Potential BCG Vaccination – COVID-19 Molecular Link | Coronaviruses | 2020 | 3 |
| 37 | A Preliminary Review on Novel Coronavirus Disease: COVID-19 | Coronaviruses | 2020 | 3 |
| 38 | Computational Study Reveals the Inhibitory Effects of Chemical Constituents from Azadirachta indica (Indian Neem) Against Delta and Omicron Variants of SARS-CoV-2 | Coronaviruses | 2022 | 3 |
| 39 | The COVID-19 and Ageism in Social Media | Coronaviruses | 2020 | 2 |
| 40 | In Silico Insight into the Inhibitory Effects of Active Antidiabetic Compounds from Medicinal Plants Against SARS-CoV-2 Replication and Posttranslational Modification | Coronaviruses | 2022 | 2 |
| 41 | Virtual Screening of the Flavonoids Compounds with the SARS-CoV-2 3C-like Protease as the Lead Compounds for the COVID-19 | Coronaviruses | 2021 | 2 |
| 42 | Prevention and management of SARS-CoV-2 infection among the health care workers | Coronaviruses | 2021 | 2 |
| 43 | Functionalized photocatalytic nanocoatings for inactivating COVID-19 virus residing on surfaces of public and healthcare facilities | Coronaviruses | 2021 | 2 |
| 44 | Synthetic Lung Surfactant Treatment for COVID-19 Pneumonia | Coronaviruses | 2021 | 2 |
| 45 | Vitamin D3 Deficiency and COVID-19 | Coronaviruses | 2021 | 2 |
| 46 | COVID-19: Insights into Structure-Function Relationship, Drug Targets and Drug Design Strategies for Novel-Coronavirus 2019 | Coronaviruses | 2021 | 2 |
| 47 | Current Advances in Novel SARS-CoV-2 Disease (COVID-19) Treatment and Intervention Strategies | Coronaviruses | 2021 | 2 |
| 48 | An Overview on COVID-19: Clinical Features, Treatment and Prevention | Coronaviruses | 2021 | 2 |
| 49 | Novel Corona-Virus Disease 2019 (COVID-19): A Perilous Life- Threatening Epidemic | Coronaviruses | 2021 | 2 |
| 50 | COVID-19 Epigenetics and Implications for Public Health | Coronaviruses | 2021 | 2 |
